- $93.55m
- -$49.64m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 9.91 | 10.1 | 41.2 | 71.4 | 91.4 |
Operating Profit | -9.91 | -10.1 | -41.2 | -71.4 | -91.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.7 | -12 | -67.8 | -70.2 | -85.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.7 | -12 | -67.9 | -71.5 | -86.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.7 | -12 | -67.9 | -71.5 | -86.1 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.5 | -14.6 | -75 | -71.5 | -86.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -70.6 | -0.526 | -2.6 | -2.48 | -1.98 |